Abstract
Four U.S. National Football League teams required vaccination certification against the SARS-CoV-2 virus of attendees at home games during the 2021 season. Using daily data on confirmed cases and vaccinations in counties surrounding these stadiums and stadiums that did not require certification, this study estimates the effects of the certification policy. Ordinary least squares regression was used to estimate the change in community spread of the virus after home games and away games relative to weeks that the teams did not play (bye weeks).
Compared to counties in metropolitan areas near stadiums with no certification requirement, counties near stadiums that had a vaccination requirement had significantly less cases 14 days after home games. In the six weeks leading up to the beginning of the season, percent vaccinated increased in counties that were near stadiums requiring vaccination certification only if the prevalent preseason vaccination rate was relatively low. Required vaccination certification at venues for large gatherings appear to slow virus spread generally in nearby communities and increases vaccination percentages in areas with lower prevalent vaccination percentages.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
